TODD STRATEGY GROUP

Lobbying for NOVO NORDISK INC. · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Implementation of Inflation Reduction Act. Pharmacy Benefit Manager Reform. Health care supply chain. 340B. Treat and Reduce Obesity Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.